Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001558370-24-013333
Filing Date
2024-10-16
Accepted
2024-10-16 13:31:08
Documents
4

Document Format Files

Seq Description Document Type Size
1 S-3/A tmb-20241016xs3a.htm S-3/A 488321
2 EX-23.1 tmb-20241016xex23d1.htm EX-23.1 4491
3 EX-FILING FEES tmb-20241016xexfees.htm EX-FILING FEES 285774
4 GRAPHIC tmb-20241016xs3a001.jpg GRAPHIC 11611
  Complete submission text file 0001558370-24-013333.txt   795980
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-280229 | Film No.: 241374119
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)